Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (121-130 of 220) with videos related to

Pageof 22
Sort By:
Physics and Imaging in Radiation Oncology|January 18, 2021
Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring <sup>18</sup>F-FDG-PET/CTTineke W H Meijer, Robin Wijsman, Edwin A Usmanij, et al.
Cancers|December 11, 2019
ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy BiomarkerEva-Leonne Göttgens, Corina Nam van den Heuvel, Monique C de Jong, et al.
Radiation Oncology (London, England)|June 19, 2012
(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistryAnders E Hansen, Annemarie T Kristensen, Jesper T Jørgensen, et al.
Plos Medicine|December 1, 2018
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics studyAhmed Hosny, Chintan Parmar, Thibaud P Coroller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 13, 2015
GABARAPL1 is required for increased EGFR membrane expression during hypoxiaTom G Keulers, Marco B E Schaaf, Hanneke J M Peeters, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2011
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validationHugo J W L Aerts, Johan Bussink, Wim J G Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
The Predictive Value of Early In-Treatment <sup>18</sup>F-FDG PET/CT Response to Chemotherapy in Combination with Bevacizumab in Advanced Nonsquamous Non-Small Cell Lung CancerEdwin A Usmanij, Tinatin Natroshvili, Johanna N H Timmer-Bonte, et al.
Thoracic Cancer|November 1, 2019
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypesTineke W H Meijer, Monika G Looijen-Salamon, Jasper Lok, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Toll-like receptor 4 in bone marrow-derived cells as well as tissue-resident cells participate in aggravating autoimmune destructive arthritisBen T van den Brand, Shahla Abdollahi-Roodsaz, Miranda B Bennink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2013
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcomeBianca A W Hoeben, Esther G C Troost, Paul N Span, et al.
Pageof 22

Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
Physics and Imaging in Radiation Oncology|January 18, 2021
Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring <sup>18</sup>F-FDG-PET/CTTineke W H Meijer, Robin Wijsman, Edwin A Usmanij, et al.
Cancers|December 11, 2019
ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy BiomarkerEva-Leonne Göttgens, Corina Nam van den Heuvel, Monique C de Jong, et al.
Radiation Oncology (London, England)|June 19, 2012
(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistryAnders E Hansen, Annemarie T Kristensen, Jesper T Jørgensen, et al.
Plos Medicine|December 1, 2018
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics studyAhmed Hosny, Chintan Parmar, Thibaud P Coroller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 13, 2015
GABARAPL1 is required for increased EGFR membrane expression during hypoxiaTom G Keulers, Marco B E Schaaf, Hanneke J M Peeters, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2011
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validationHugo J W L Aerts, Johan Bussink, Wim J G Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
The Predictive Value of Early In-Treatment <sup>18</sup>F-FDG PET/CT Response to Chemotherapy in Combination with Bevacizumab in Advanced Nonsquamous Non-Small Cell Lung CancerEdwin A Usmanij, Tinatin Natroshvili, Johanna N H Timmer-Bonte, et al.
Thoracic Cancer|November 1, 2019
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypesTineke W H Meijer, Monika G Looijen-Salamon, Jasper Lok, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Toll-like receptor 4 in bone marrow-derived cells as well as tissue-resident cells participate in aggravating autoimmune destructive arthritisBen T van den Brand, Shahla Abdollahi-Roodsaz, Miranda B Bennink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2013
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcomeBianca A W Hoeben, Esther G C Troost, Paul N Span, et al.
Pageof 22